VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ISA 2022 | How novel technologies and machine learning are impacting drug research in amyloidosis

Joost Schymkovitz, PhD, KU Leuven, Leuven, Belgium, briefly explains how novel technologies and machine learning are impacting drug research and allowing researchers to better understand the structure of amyloid proteins. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter